- Exchange: Tel Aviv
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Teva Pharmaceutical Industries Ltd
+ Add to WatchlistTEVA:IT
14,700.00 ILs 30.00 0.20%As of 02:54:49 ET on 05/22/2013.
Snapshot for Teva Pharmaceutical Industries Ltd (TEVA)
| Open: | 14,720.00 | Day's Range: | 14,690.00 - 14,720.00 | Volume: | 37,013 |
|---|---|---|---|---|---|
| Previous Close: | 14,670.00 | 52wk Range: | 13,510.00 - 16,900.00 | 1-Yr Rtn: | +2.13% |
Key Statistics for TEVA
| Current P/E Ratio (ttm) | 20.2748 |
|---|---|
| Estimated P/E(12/2013) | 7.7595 |
| Relative P/E vs. TA-100 | 1.1140 |
| Earnings Per Share (USD) (ttm) | 1.9760 |
| Est. EPS (USD) (12/2013) | 5.1630 |
| Est. PEG Ratio | 0.5542 |
| Market Cap (M ILS) | 124,841.70 |
| Shares Outstanding (M) | 851.00 |
| 30 Day Average Volume | 343,811 |
| Price/Book (mrq) | 1.5085 |
| Price/Sale (ttm) | 1.7303 |
| Dividend Indicated Gross Yield | 3.14% |
| Cash Dividend (ILs) | 115.0000 |
| Last Dividend | 05/20/2013 |
| 5 Year Dividend Growth | 20.39% |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for TEVA
Company Profile & Key Executives for TEVA
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
| Phillip FrostChairman | Jeremy M LevinPresident/CEO |
| Allan ObermanPresident & CEO:Americas | Robert Koremans "Rob"President & CEO:Europe |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
TEVA News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page